As of 2025-07-01, the EV/EBITDA ratio of Repligen Corp (RGEN) is -145.46. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RGEN's latest enterprise value is 6,820.04 mil USD. RGEN's TTM EBITDA according to its financial statements is -46.89 mil USD. Dividing these 2 quantities gives us the above RGEN EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 17.2x | 15.0x |
| Forward P/E multiples | 19.4x - 22.6x | 20.2x |
| Fair Price | (8.12) - 14.95 | 2.08 |
| Upside | -106.5% - -88.0% | -98.3% |
| Date | EV/EBITDA |
| 2025-06-30 | -145.44 |
| 2025-06-27 | -144.48 |
| 2025-06-26 | -145.26 |
| 2025-06-25 | -145.03 |
| 2025-06-24 | -144.23 |
| 2025-06-23 | -140.34 |
| 2025-06-20 | -138.83 |
| 2025-06-18 | -137.26 |
| 2025-06-17 | -141.42 |
| 2025-06-16 | -147.51 |
| 2025-06-13 | -149.22 |
| 2025-06-12 | -153.75 |
| 2025-06-11 | -154.59 |
| 2025-06-10 | -155.63 |
| 2025-06-09 | -154.21 |
| 2025-06-06 | -150.16 |
| 2025-06-05 | -148.24 |
| 2025-06-04 | -148.06 |
| 2025-06-03 | -145.48 |
| 2025-06-02 | -138.50 |
| 2025-05-30 | -137.90 |
| 2025-05-29 | -142.99 |
| 2025-05-28 | -141.63 |
| 2025-05-27 | -143.26 |
| 2025-05-23 | -138.00 |
| 2025-05-22 | -140.75 |
| 2025-05-21 | -140.46 |
| 2025-05-20 | -149.31 |
| 2025-05-19 | -147.63 |
| 2025-05-16 | -148.00 |
| 2025-05-15 | -144.12 |
| 2025-05-14 | -149.85 |
| 2025-05-13 | -154.05 |
| 2025-05-12 | -156.65 |
| 2025-05-09 | -144.09 |
| 2025-05-08 | -149.62 |
| 2025-05-07 | -148.46 |
| 2025-05-06 | -152.67 |
| 2025-05-05 | -165.28 |
| 2025-05-02 | -165.99 |
| 2025-05-01 | -160.82 |
| 2025-04-30 | -161.77 |
| 2025-04-29 | -163.49 |
| 2025-04-28 | -168.53 |
| 2025-04-25 | -169.87 |
| 2025-04-24 | -170.44 |
| 2025-04-23 | -165.85 |
| 2025-04-22 | -162.89 |
| 2025-04-21 | -154.16 |
| 2025-04-17 | -152.19 |